Xu-Feng Chen

机构：Shanghai Medical College of Fudan University, Duke University, Fudan University Shanghai Cancer Center

发表论文 7 篇 · 总被引 97 次 · h-index 4

代表论文

• A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer (2024 · JCI Insight · 被引 52)
• Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus (2023 · Military Medical Research · 被引 35)
• DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer (2024 · Epigenetics · 被引 4)
• Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer (2016 · Asian Journal of Andrology · 被引 4)
• Real-world data analysis of next-generation sequencing and corresponding clinical characteristics in thyroid tumor (2024 · Endocrine Connections · 被引 2)
• Abstract 3514: DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer (2020 · Cancer Research)